BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27893546)

  • 1. Cutaneous Vasculitis in a Patient with Crohn's Disease Treated with Adalimumab.
    Cury DB; de Souza AW; Vianna GA; Odashiro D; Farias A; Moss AC
    Inflamm Bowel Dis; 2017 Jan; 23(1):E1-E2. PubMed ID: 27893546
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukocytoclastic vasculitis complicating adalimumab therapy for Crohn's disease: Report of three cases.
    Bernardes C; Carvalho D; Saiote J; Ramos J
    Gastroenterol Hepatol; 2018; 41(7):442-443. PubMed ID: 29054318
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adalimumab vasculitis in a patient with Crohn's disease].
    Muñoz Villafranca C; Izu Belloso RM; Bravo Rodriguez MT; Basterra Olabarrieta S
    Gastroenterol Hepatol; 2013 Apr; 36(4):296-7. PubMed ID: 23522950
    [No Abstract]   [Full Text] [Related]  

  • 4. Adalimumab-induced leukocytoclastic vasculitis in a Crohn's disease patient.
    Cançado GGL; Nardelli MJ; Gouthier MAD
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):453. PubMed ID: 33512843
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukocytoclastic Vasculitis Related to Ustekinumab in a Crohn's Disease Patient: First Case Report and Literature Review.
    Costa-Moreira P; Lopes S; Santos AL; Pedrosa AF; Andrade P; Portugal R; Macedo G
    J Crohns Colitis; 2020 Feb; 14(2):274-276. PubMed ID: 31267125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Attack of Henoch-Schönlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn's Disease.
    Condamina M; Diaz E; Jamart C; Loget J; Durlach A; Salmon JH; Cadiot G; Viguier M
    J Crohns Colitis; 2020 May; 14(4):538-542. PubMed ID: 31589303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
    Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent Purpura Development Associated with Leukocytoclastic Vasculitis Induced by Infliximab for Crohn's Disease.
    Kishimoto K; Kawashima K; Fukunaga M; Kotani S; Sonoyama H; Oka A; Mishima Y; Oshima N; Ishimura N; Ishikawa N; Maruyama R; Ishihara S
    Intern Med; 2021 Feb; 60(3):385-389. PubMed ID: 32863363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocytoclastic Vasculitis and Dermal Perivascular Hemophagocytosis Associated With Adalimumab Therapy for Rheumatoid Arthritis.
    Muto J; Usami J; Watanabe D
    Am J Dermatopathol; 2018 Jan; 40(1):57-59. PubMed ID: 28719435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of Sweet syndrome under anti-TNF.
    Banse C; Sobocinski V; Savoye G; Avenel G; Vittecoq O
    Clin Rheumatol; 2015 Nov; 34(11):1993-4. PubMed ID: 26292633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous Vasculitis After Ustekinumab Induction in Crohn's Disease.
    Chugh R; Proctor DD; Little A; Myung P; Cowper S; Imaeda S; Pashankar DS; Al-Bawardy B
    Inflamm Bowel Dis; 2021 Feb; 27(3):e30-e31. PubMed ID: 33179735
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
    Fujikawa K; Kawakami A; Hayashi T; Iwamoto N; Kawashiri SY; Aramaki T; Ichinose K; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Ida H; Origuchi T; Eguchi K
    Mod Rheumatol; 2010 Feb; 20(1):86-9. PubMed ID: 19812889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced lupus with leukocytoclastic vasculitis: a rare expression associated with adalimumab.
    Amarante CF; Acedo LM; Rabay FM; Campos Bdo E; Lira ML; Mandelbaum SH
    An Bras Dermatol; 2015; 90(3 Suppl 1):121-4. PubMed ID: 26312693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Unusual Cause of Skin Rash in Crohn's Disease.
    Chebli JMF; de Oliveira Moreira B; da Rocha Ribeiro TC
    Gastroenterology; 2018 Sep; 155(3):618-620. PubMed ID: 29409941
    [No Abstract]   [Full Text] [Related]  

  • 15. Crohn's disease and acute leukocytoclastic vasculitis of skin.
    Zlatanic J; Fleisher M; Sasson M; Kim P; Korelitz BI
    Am J Gastroenterol; 1996 Nov; 91(11):2410-3. PubMed ID: 8931427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous Vasculitis Caused by Anti-Tumor Necrosis Factor Therapy: A Case Report.
    Shivaji UN; Awasthi AK; Aherne R
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):e1-2. PubMed ID: 25998787
    [No Abstract]   [Full Text] [Related]  

  • 17. Solitary facial cutaneous chronic inflammatory lesions induced by anti-tumour necrosis factor-α antagonist.
    Haro-Gabaldón V; Ruiz Molina I; Haro-González-Vico V; Solís García E
    Clin Exp Dermatol; 2019 Jan; 44(1):80-82. PubMed ID: 30255515
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximab.
    McIlwain L; Carter JD; Bin-Sagheer S; Vasey FB; Nord J
    J Clin Gastroenterol; 2003; 36(5):411-3. PubMed ID: 12702983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ustekinumab-induced leukocytoclastic vasculitis in a young male with Crohn's disease.
    Zhang XP; Wang H; Zhu LR
    Dig Liver Dis; 2024 Jun; 56(6):1105-1106. PubMed ID: 38521672
    [No Abstract]   [Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn's disease treated with adalimumab.
    Martín Varas C; Heras M; Saiz A; Coloma R; Calle L; Callejas R; Molina Á; Rodríguez MA; Fernández-Reyes Luis MJ
    Nefrologia; 2017; 37(5):560-561. PubMed ID: 28946973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.